Imagene provides a disruptive AI-based genomic testing solution to assist cancer patients in receiving the optimal treatment that medicine can offer by making genomic testing accessible and leverage their biopsy image for personalized therapeutic strategies. Cancer diagnostic focus on pathological and molecular testing. Both are conducted by advanced technology which depends on limited amount of tissue, and therefore does not allow wide and extensive diagnosis. Further, genomic analysis, infrastructure and personnel are highly expensive and the overall diagnosis require prolong time to report. These four factors can be improve significantly with in silico and AI based algorithms. We believe that no structure and assumptions should become a barrier to personal treatment. Imagene brings the potential of accurate, fast, low cost, actionable, standardized, and routine screening to all cancer patients. Assist cancer patients to receive the optimal treatment that medicine can offer by making genomic testing accessible and leverage their histological data for personalized therapeutic strategies.
